Check out our multimedia coverage of regulatory issues, commercial developments, and interviews with industry experts, including "green voices" in our Climate and Pharma series.
Last month, the US Food and Drug Administration issued a draft guidance that could dramatically reshape how we conduct cancer clinical trials. Will preclinical drug developers need to adapt, too?
Clear Scientific, a Cambridge, MA biotech, is testing its therapeutic in clinical trials for fentanyl and methamphetamine overdose, and plans to expand its use to the polydrug epidemic
.jpg?crop=false&position=c&q=80&color=ffffffff&u=8anjqk&w=400&h=267)
